Customer Experience · August 6, 2026
RethinkFirst Names Shane Wilson Chief Customer Officer
RethinkFirst has appointed Shane Wilson as CCO to lead end-to-end customer experience across its behavioural health technology platform serving clinicians, educators and families.
What happened
RethinkFirst, a behavioural health technology company focused on supporting individuals with autism and developmental differences, has appointed Shane Wilson as its Chief Customer Officer. Wilson steps into the newly elevated role with a remit to oversee the end-to-end customer journey — spanning onboarding, ongoing support and long-term retention — as the company scales its platform across clinical and educational settings.
The appointment signals a deliberate organisational move to place customer experience at the executive table, reflecting a broader trend among health-tech firms of treating post-sale relationship management as a strategic growth lever rather than an operational afterthought.
Why it matters
In behavioural health technology, the stakes of poor customer experience extend well beyond churn metrics. The end users of platforms like RethinkFirst's are clinicians, educators and, ultimately, children and families navigating complex care pathways. When onboarding is friction-heavy or support is slow, the downstream effect is felt not just in contract renewals but in the quality and consistency of care delivered. Elevating a CCO to the C-suite is an acknowledgement that experience design in this sector is inseparable from clinical outcomes.
From a behavioural economics perspective, the move also reflects an understanding of switching costs and trust asymmetry in healthcare SaaS. Organisations that embed a dedicated customer-success leadership function early tend to reduce the perceived risk of adoption — a critical factor when buyers are risk-averse procurement teams in schools and healthcare networks. A CCO with cross-functional authority can align product, support and commercial teams around the moments that most influence renewal decisions.
The Renascence take
Most commentary on CCO appointments focuses on retention and revenue. The more interesting question here is whether the role is designed to influence the product itself — or merely to manage reactions to it.
The distinction between a CCO who owns the voice of the customer upstream and one who simply manages satisfaction scores downstream is enormous. In high-stakes sectors like behavioural health, the former can reshape how features are prioritised and how care workflows are designed; the latter is essentially a sophisticated complaints function. RethinkFirst's real test will be whether Wilson has a seat at the product and clinical roadmap table — not just the renewals conversation. Customer-obsessed operators in health-tech should ask themselves: does our CX leadership have the authority to say no to a product decision, or only to apologise for it afterwards?
Sources
This briefing was written by the Renascence newsdesk, synthesising reporting from the outlets below. Follow the links for the original coverage.
More in Customer Experience
Stay ahead of CX
Get the signal, not the noise.
The stories shaping customer experience — plus the Journal and Experience Loom — in your inbox.